Small dense low-density lipoproteins and associated risk factors in patients with stroke

Cerebrovascular Diseases

Volumn 27, Issue 1, 2009, Pages 99-104

  Zhao, Chun Xia ^a   Cui, Ying Hua ^a   Fan, Qiao ^a   Wang, Pei Hua ^a   Hui, Ruitai ^b   Cianflone, Katherine ^c   Wang, Dao Wen ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b FUWAI HOSPITAL   (China)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Chinese people, small dense low density lipoproteins; Risk factors; Stroke

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GEL ELECTROPHORESIS; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; STROKE PATIENT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHINA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HEMODYNAMICS; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; STROKE;

EID: 56449084286     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000175768     Document Type: Article

References (32)

1. Helgason CM, Wolf PA: American Heart Association Prevention Conference IV: prevention and rehabilitation of stroke: executive summary. Circulation 1997;96:701-707.
2. Hong Y, Bots ML, Pan X, Hofman A, Grobbee DE, Chen H: Stroke incidence and mortality in rural and urban Shanghai from 1984 through 1991. Findings from a community-based registry. Stroke 1994;25:1165-1169.
3. Kannel WB, Castelli WP, Gordon T, McNamara PM: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971;74:1-12.
4. Arsenault BJ, Lemieux I, Després JP, Wareham NJ, Luben R, Kastelein JJ, Khaw KT, Boekholdt SM: Cholesterol levels in small LDL particles predict the risk of coronary heart disease in the EPIC-Norfolk prospective population study. Eur Heart J 2007;28:2770-2777.
5. Rajman I, Eacho PI, Chowienczyk PJ, Ritter JM: LDL particle size: an important drug target? Br J Clin Pharmacol 1999;48:125-133.
6. Rajman I, Kendall MJ, Cramb R, Holder RL, Salih M, Gammage MD: Investigation of low density lipoprotein subfractions as a coronary risk factor in normotriglyceridaemic men. Atherosclerosis 1996;125:231-242.
7. Kwon SW, Yoon SJ, Kang TS, Kwon HM, Kim JH, Rhee J, Lee SJ, Park JK, Lim JY, Yoon YW, Hong BK: Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome. Yonsei Med J 2006;47:405-414.
8. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J: Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 1994;106:241-253.
9. Paciaroni M, Hennerici M, Agnelli G, Bogousslavsky J: Statins and stroke prevention. Cerebrovasc Dis 2007;24:170-182.
10. Vivancos-Mora J, Gil-Núñez AC: Lipids and stroke: the opportunity of lipid-lowering treatment. Cerebrovasc Dis 2005;20:53-67.
11. Skoglund-Andersson C, Tang R, Bond MG, de Faire U, Hamsten A, Karpe F: LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men. Arterioscler Thromb Vasc Biol 1999;19:2422-2430.
12. Landray MJ, Sagar G, Muskin J, Murray S, Holder RL, Lip GY: Association of atherogenic low-density lipoprotein subfractions with carotid atherosclerosis. QJM 1998;91:345-351.
13. Liu M-L, Ylitalo K, Nuotio I, Salonen R, Salonen JT, Taskinen MR: Association between carotid intima-media thickness and low-density lipoprotein size and susceptibility of low-density lipoprotein to oxidation in asymptomatic members of familial combined hyperlipidemia families. Stroke 2002;33:1255-1260.
14. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
15. Krauss RM, Burke DJ: Identification of multiple subclasses of plasma low density lipoproteins in normal humans. J Lipid Res 1982;23:97-104.
16. Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM: Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-1921.
17. Coresh J, Kwiterovich PO Jr, Smith HH, Bachorik PS: Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women. J Lipid Res 1993;34:1687-1697.
18. Austin MA, Rodriguez BL, McKnight B, McNeely MJ, Edwards KL, Curb JD, Sharp DS: Low-density lipoprotein particle size, triglycerides, and high-density lipoprotein cholesterol as risk factors for coronary heart disease in older Japanese-American men. Am J Cardiol 2000;86:412-416.
19. Lamarche B, Tchernof A, Moorjani S, Cantin B, Dagenais GR, Lupien PJ, Després JP: Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study. Circulation 1997;95:69-75.
20. Gardner CD, Fortmann SP, Krauss RM: Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. JAMA 1996;276:875-881.
21. Stampfer MJ, Krauss RM, Ma J, Blanche PJ, Holl LG, Sacks FM, Hennekens CH: A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction. JAMA 1996;276:882-888.
22. Nigon F, Lesnik P, Rouis M, Chapman MJ: Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor. J Lipid Res 1991;32:1741-1753.
23. La Belle M, Krauss RM: Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patterns. J Lipid Res 1990;31:1577-1588.
24. Anber V, Griffin BA, McConnell M, Packard CJ, Shepherd J: Influence of plasma lipid and LDL-subfraction profile on the interaction between low density lipoprotein with human arterial wall proteoglycans. Atherosclerosis 1996;124:261-271.
25. de Graaf J, Hak-Lemmers HL, Hectors MP, Demacker PN, Hendriks JC, Stalenhoef AF: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 1991;11:298-306.
26. Felmeden DC, Spencer CG, Blann AD, Beevers DG, Lip GY: Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment. Hypertension 2003;41:528-533.
27. Vakkilainen J, Steiner G, Ansquer JC, Aubin F, Rattier S, Foucher C, Hamsten A, Taskinen MR, DAIS Group: Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS). Circulation 2003;107:1733-1737.
28. He J, Klag MJ, Wu Z, Whelton PK: Stroke in the People's Republic of China. 2. Meta-analysis of hypertension and risk of stroke. Stroke 1995;26:2222-2227.
29. Whisnant JP: Modeling of risk factors for ischemic stroke: the Willis Lecture. Stroke 1997;28:1840-1844.
30. Sato A, Asakura Y, Yokota C, Suzuki M, Tsushima M, Kuriyama Y, Sawada T, Yamaguchi T, Kobayashi M, Harano Y: Lipoprotein disorder in brain infarction and hemorrhage. Int J Clin Lab Res 1998;28:39-46.
31. Ai M, Otokozawa S, Asztalos BF, Nakajima K, Stein E, Jones PH, Schaefer EJ: Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels. Am J Cardiol 2008;101:315-318.
32. Rizzo M, Berneis K: Who needs to care about small, dense low-density lipoproteins? Int J Clin Pract 2007;61:1949-1956.